Altshuler Shaham’s CONMED CNMD Stock Holding History

Altshuler Shaham’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-617	Closed	-$92K	–	471
2022 Q1	$92K	Buy	617 +281	+84%	+$39.2K	﹤0.01%	275
2021 Q4	$48K	Buy	+336	New	+$47.6K	﹤0.01%	435
2021 Q3	–	Sell	-826	Closed	-$114K	–	537
2021 Q2	$114K	Buy	+826	New	+$113K	﹤0.01%	304
2020 Q2	–	Sell	-146	Closed	-$8K	–	385
2020 Q1	$8K	Sell	146 -125	-46%	-$11.5K	﹤0.01%	310
2019 Q4	$30K	Sell	271 -12	-4%	-$1.28K	﹤0.01%	220
2019 Q3	$27K	Sell	283 -37	-12%	-$3.47K	﹤0.01%	206
2019 Q2	$27K	Buy	+320	New	+$26.3K	﹤0.01%	194
2018 Q4	–	Sell	-86	Closed	-$7K	–	262
2018 Q3	$7K	Buy	+86	New	+$6.65K	﹤0.01%	197

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Altshuler Shaham's CNMD Position: Q2 2022 in Review

Altshuler Shaham sold out of CONMED (CNMD) in Q2 2022, closing a stake of 617 shares — an estimated $92K sold.

Altshuler Shaham first reported a position in CNMD in Q3 2018 and held it in 8 quarters. The position peaked at $114K in Q2 2021. 279 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

Altshuler Shaham reported no remaining CONMED position as of Q2 2022 after selling out during the quarter.
Altshuler Shaham sold 617 CONMED shares in Q2 2022, an estimated $92K.
Altshuler Shaham first reported a position in CONMED in Q3 2018 and held it in 8 quarters.
Altshuler Shaham's CONMED position peaked at $114K in Q2 2021.
279 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Altshuler Shaham's 13F filing for Q2 2022, filed 10 Aug 2022.